Locations:
Search
Recommendations on identifying and managing neurodevelopmental and related challenges
Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies
Advances in genomics, spinal fluid analysis, wearable-based patient monitoring and more
An update on the technology from the busiest Gamma Knife center in the Americas
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Novel approach begins reinnervation before tumor resection, preserving a young woman’s smile
Researchers use AI tools to compare clinical events with continuous patient monitoring
Combining dual inhibition with anti-PD1 therapy yielded >60% rate of complete tumor regression
A range of pituitary tumor-related conditions all benefit from a multidisciplinary approach
Cleveland Clinic researchers pursue answers on basic science and clinical fronts
Insights from 15 years of experience of Cleveland Clinic’s spine tumor board
Advertisement
Advertisement